Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrik Isbarn

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancerAlexander T El Gammal, Michael Brüchmann, Jozef Zustin, et al.
BJU International|January 20, 2011
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohortRobert S Svatek, Shahrokh F Shariat, Giacomo Novara, et al.
BJU International|September 16, 2009
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancerHendrik Isbarn, Pierre I Karakiewicz, Sascha A Ahyai, et al.
Urologia Internationalis|June 11, 2011
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgeryPhilipp Nuhn, Patrick J Bastian, Giacomo Novara, et al.
BJU International|November 17, 2009
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomyShahrokh F Shariat, Guilherme Godoy, Yair Lotan, et al.
The Journal of Urology|July 21, 2009
p53 predictive value for pT1-2 N0 disease at radical cystectomyShahrokh F Shariat, Yair Lotan, Pierre I Karakiewicz, et al.
The Journal of Urology|August 21, 2010
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stageLars Budäus, Hendrik Isbarn, Christian Eichelberg, et al.
European Urology Focus|July 21, 2017
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov DatabaseAlexandros Tsikkinis, Nikola Cihoric, Gianluca Giannarini, et al.
The Journal of Urology|November 28, 2009
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patientsDerya Tilki, Robert S Svatek, Pierre I Karakiewicz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Unilateral prostate cancer cannot be accurately predicted in low-risk patientsHendrik Isbarn, Pierre I Karakiewicz, Susanne Vogel, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancerAlexander T El Gammal, Michael Brüchmann, Jozef Zustin, et al.
BJU International|January 20, 2011
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohortRobert S Svatek, Shahrokh F Shariat, Giacomo Novara, et al.
BJU International|September 16, 2009
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancerHendrik Isbarn, Pierre I Karakiewicz, Sascha A Ahyai, et al.
Urologia Internationalis|June 11, 2011
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgeryPhilipp Nuhn, Patrick J Bastian, Giacomo Novara, et al.
BJU International|November 17, 2009
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomyShahrokh F Shariat, Guilherme Godoy, Yair Lotan, et al.
The Journal of Urology|July 21, 2009
p53 predictive value for pT1-2 N0 disease at radical cystectomyShahrokh F Shariat, Yair Lotan, Pierre I Karakiewicz, et al.
The Journal of Urology|August 21, 2010
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stageLars Budäus, Hendrik Isbarn, Christian Eichelberg, et al.
European Urology Focus|July 21, 2017
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov DatabaseAlexandros Tsikkinis, Nikola Cihoric, Gianluca Giannarini, et al.
The Journal of Urology|November 28, 2009
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patientsDerya Tilki, Robert S Svatek, Pierre I Karakiewicz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Unilateral prostate cancer cannot be accurately predicted in low-risk patientsHendrik Isbarn, Pierre I Karakiewicz, Susanne Vogel, et al.
Pageof 14